Avoid common mistakes on your manuscript.
Recently, Baker et al. [1] reported p25α and α-synuclein reactivity in glial cytoplasmic inclusions (GCI) in oligendroglia of multiple system atrophy (MSA) but p25α immunoreactivity in neuronal cytoplasmic inclusions (NCI) co-localized with α-synuclein labeling in only about 40%. These data can be largely confirmed by own studies in two cases each of MSA and Parkinson disease (PD), using formalin-fixed, paraffin-embedded slides and routine peroxidase immunohistochemistry for α-synuclein (monoclonal and polyclonal antibodies, Chemicon, Temecula, CA, USA) and p25α (purified polyclonal rabbit anti IgG, diluted 1:200 and 1:1000; gift of Prof. P. H. Jensen, Department of Medical Biochemistry, University of Aarhus, Denmark).
In MSA, anti-p25α labeled many GCI in oligodendroglia, virtually identical in localization and intensity with α-synuclein immunoreactivity, whereas it did not stain normal oligodendroglia [4]. In MSA, anti-p25α labeled only part of NCIs, virtually all of them being negative for α-synuclein [3].
In PD, the vast majority of cortical Lewy bodies showing intense α-synuclein immunoreactivity were negative for p25α, whereas subcortical Lewy bodies, consistently positive for α-synuclein, showed inconsistent p25α immunoreactivity.
While p25α-positive subcortical Lewy bodies in PD showed rather diffuse appearance, in MSA p25α-positive NCIs often displayed a punctate appearance of immunoreactive structures, as described by Baker et al. [1], suggesting that protein aggregation may occur, although p25α is folded and flexible without overt tendency for aggregation [5]. Brain-specific p25α was identified as a candidate that preferentially binds α-synuclein in its aggregated state [4]. Since p25α shares the property of heat stability with the aggregation-prone proteins tau and α-synuclein [4], these properties and the abnormal location of p25α suggest that aggregation of both p25α and tau-protein probably induced by additional co-factors may impair neuronal function, as suggested recently for Alzheimer disease (AD) neurons, showing co-localization of p25α and tau-positive pretangle structures [3], but not in other tauopathies. Since p25α-immunopositive neurons in both MSA and AD ultrastructurally show “twisted” and “straight” filaments [6], its abnormal expression may occur in a variety of neuronal types in diverse neurodegenerative disorders, in particular synucleinopathies, and may indicate some synergistic reaction with α-synuclein, as has been suggested for α-synuclein and tau [2, 7], which may also occur in PD.
References
Baker KG, Huang Y, McCann H, Gai WP, Jensen PH, Halliday GM (2006) P25alpha immunoreactive but alpha-synuclein immunonegative neuronal inclusions in multiple system atrophy. Acta Neuropathol (Berl) 111:193–195
Galpern WR, Lang AE (2006) Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann Neurol 59:449–458
Kovacs GG, Laszlo L, Kovacs J, Jensen PH, Lindersson E, Botond G, Molnar T, Perczel A, Hudecz F, Mezo G, Erdei A, Tirian L, Lehotzky A, Gelpi E, Budka H, Ovadi J (2004) Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies. Neurobiol Dis 17:155–162
Lindersson E, Beedholm R, Hojrup P, Moos T, Gai W, Hendil KB, Jensen PH (2004) Proteasomal inhibition by alpha-synuclein filaments and oligomers. J Biol Chem 279:12924–12934
Otzen DE, Lundvig DM, Wimmer R, Nielsen LH, Pedersen JR, Jensen PH (2005) p25alpha is flexible but natively folded and binds tubulin with oligomeric stoichiometry. Protein Sci 14:1396–1409
Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson’s disease and dementia with Lewy bodies. Neurosci Lett 251:205–208
Wenning GK, Jellinger KA (2005) The role of alpha-synuclein and tau in neurodegenerative movement disorders. Curr Opin Neurol 18:357–362
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jellinger, K.A. P25α immunoreactivity in multiple system atrophy and Parkinson disease. Acta Neuropathol 112, 112 (2006). https://doi.org/10.1007/s00401-006-0075-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-006-0075-7